1620
J.M. Otero et al. / Tetrahedron 68 (2012) 1612e1621
½
a 2D0
ꢄ
ꢀ86.4 (c 1.5, CHCl3); IR (
n
, cmꢀ1, NaCl): 1558; 1367; 1H NMR (
d
,
acetone (1 mL). The solids were filtered off and the filtrate was
concentrated to dryness under vacuum to give compound 26
(45 mg, 92% yield) as a yellow oil, which was used without further
purification.
ppm, CDCl3): 1.29 (s, 3H, CH3); 1.47 (s, 3H, CH3); 3.79 (s, 3H, OCH3);
3.83 (d, 1H, J¼2.8 Hz, H-3); 3.93 (s, 3H, OCH3); 4.50 (d, 1H,
J¼12.0 Hz, CH2Ph); 4.60 (dd, 1H, J¼8.0, 2.8 Hz, H-4); 4.63 (d, 1H,
J¼3.7 Hz, H-2); 4.70e4.74 (m, 1H, H-5); 4.75 (d, 1H, J¼12.0 Hz,
CH2Ph); 4.80 (dd, 1H, J¼12.9, 4.3 Hz, H-6); 5.01 (dd, 1H, J¼12.9,
9.6 Hz, H-6); 5.92 (d, 1H, J¼3.7 Hz, H-1); 6.62 (s, 1H, H-30);
7.33e7.42 (m, 5H, 5ꢃ HePh); 7.46 (dd, 1H, J¼8.3, 7.1 Hz, H-60); 7.52
(dd, 1H, J¼8.3, 7.1 Hz, H-70); 8.01 (d, 1H, J¼8.3 Hz, H-80); 8.19 (d, 1H,
3.1.15. (1R,2S,3S,4R,4aS,11bS)-2-(Benzyloxy)-1,3,4-trihydroxy-
1,2,3,4,4a,5-hexahydro-11bH-benzo[b]carbazole-6,11-dione (1c). A
solution of compound 26 (45 mg, 0.11 mmol) in dry tetrahydrofu-
ran (3 mL) was stirred and heated at 60 ꢁC during 24 h. The solvent
was removed under vacuum and the residue purified by pre-
parative TLC (dichloromethane/methanol, 9:1) providing the benzo
[b]carbazoledione 1c (9.0 mg, 20% yield). Violet solid: mp higher
J¼8.3 Hz, H-50); 13C NMR (
d, ppm, CD3OD): 26.1, 26.6, 37.7, 55.5,
62.5, 71.4, 75.7, 79.7, 81.2, 82.0, 102.0, 104.5, 111.7, 122.2, 122.3, 124.1,
125.6, 126.3, 126.7, 127.2, 128.2, 128.4, 128.7, 136.9, 148.2, 152.2; MS
(CI, m/z, %): 509 (4, Mþ); 91 (25, [PhCH2]þ); 29 (100). Anal. Calcd for
C28H31NO8: C, 66.00; H, 6.13; N, 2.75. Found: C, 66.08, H, 6.33; N,
2.45.
than 260 ꢁC; ½a 2D0
ꢄ
þ26.0 (c 0.10, CH3COCH3); IR (
n
, cmꢀ1, NaCl): 3434
d, ppm, CD3COCD3,): 2.80 (s,
(b, OHþNH); 1661 (m, CO); 1H NMR (
1H, OH); 3.57 (dd, 1H, J¼7.3, 9.9 Hz, H-11b); 3.73 (ddd, 1H, J¼3.1, 7.5,
9.9 Hz, H-4a); 4.36 (d, 1H, J¼3.4 Hz, OH); 4.63e4.69 (m, 1H, H-2);
4.87 (d, 1H, J¼11.7 Hz, CH2Ph); 4.87e4.91 (m, 2H, H-1þH-4); 5.11 (d,
1H, J¼11.7 Hz, CH2Ph); 5.17 (d, 1H, J¼1.3 Hz, H-3); 7.26e7.51 (m, 6H,
5ꢃ HeArþH-7); 7.68 (td, 1H, J¼1.3, 7.5 Hz, H-10); 7.94e8.03 (m, 2H,
3.1.11. 3-O-Benzyl-5,6-dideoxy-5-C-(10,40-dimethoxynaphthalen-20-
yl)-6-nitro-b-L-idofuranose (22). A solution of idofuranose 21a-2
(0.390 g, 0.76 mmol) in 1,4-dioxane (6 mL), water (2 mL), and tri-
fluoroacetic acid (4 mL) was stirred at 50 ꢁC during 16 h. The solvent
was evaporated and the residue was coevaporated with toluene
(3ꢃ5 mL) to give the 3-O-benzyl-5,6-dideoxy-5-C-(30-hydroxy-
H-8þH-9), 11.42 (br s, 1H, NH); 13C NMR (
d, ppm, CD3COCD3): 42.0,
67.2, 70.6, 71.3, 76.3, 78.4, 85.9, 124.2, 127.3, 129.1, 129.8, 130.0,
130.8, 131.5, 131.9, 134.1, 137.2, 141.5, 157.7, 177.2, 182.9; MS (FABþ,
m/z, %): 407 (1, Mþ); 390 (5, [MꢀOH]þ); 91 (100, [PhCH2]þ); HRMS
calcd for C23H21NO6 [M]þ 407.136890; found 407.136897.
10,40-naphthoquinon-20-yl)-6-nitro-
b-L-idofuranose (22) as a color-
less oil, which was used in the next reaction without further
purification.
Acknowledgements
3.1.12. (1R,2S,3S,4R,5S,6S)-3-(Benzyloxy)-5-(10,40-dimethoxynaph-
thalen-20-yl)-6-nitrocyclohexane-1,2,4-triol (24). A 2% aqueous so-
lution of sodium bicarbonate (4 mL) was added to a solution of 22
(390 mg, 0.76 mmol) in methanol (12 mL) and the mixture was
stirred at rt for 24 h. The reaction mixture was acidified with acid
resin, filtered, and the solvents were evaporated under vacuum.
The residue was purified by column chromatography (dichloro-
methane/methanol/acetic acid, 10:0.5:0.2) to obtain nitro-
cyclohexanetriol 24 (310 mg, 87% yield from 21a-2). White
We thank the Spanish Ministry of Science And Innovation for
financial support (CTQ2009-08490) and for an FPU to Jose M. Otero.
We also thank the Xunta de Galicia for grants to Jose C. Barcia and
Pablo Thomas and the University of Santiago de Compostela for
a visiting professorship to Cristian O. Salas.
ꢀ
ꢀ
References and notes
amorphous solid. ½a D20
ꢄ
þ15.7 (c 2.00, CHCl3); IR (
n
, cmꢀ1, NaCl):
1. (a) The Chemistry of Functional Groups: The Chemistry of the Quinonoid Com-
pounds; Patai, S., Rappoport, Z., Eds.; Wiley: New York, NY, 1988; (b) O’Brien, P. J.
Chem. Biol. Interact. 1991, 80, 1; (c) Thomson, R. H. In Naturally Occurring Qui-
nones Chapman and Hall: London/New York, NY, 1997; (d) Duke, J. A. CRC Hand-
book of Medicinal Herbs; CRC: Boca Raton, 1985; p 470; (e) Spyroudis, S. Molecules
3434; 1557; 1371; 1H NMR (
d
, ppm, CD3COCD3): 3.61 (t, 1H,
J¼8.8 Hz, H-3); 3.75 (ddd, 1H, J¼4.3, 8.8, 9.1 Hz, H-2); 3.91 (s, 3H,
OCH3); 3.96e4.06 (m, 1H, H-5); 4.02 (s, 3H, OCH3); 4.09e4.15 (m,
1H, H-4); 4.21 (ddd, 1H, J¼4.6, 9.1, 10.3 Hz, H-1); 4.45 (d, 1H,
J¼4.3 Hz, OH-2); 4.75 (d, 1H, J¼4.6 Hz, OH-1); 4.95e5.01 (m, 3H,
OH-4þCH2Ph); 5.15 (t, 1H, J¼10.3 Hz, H-6); 7.21 (s, 1H, H-30);
7.24e7.35 (m, 3H, 3ꢃ HeAr); 7.40e7.58 (m, 4H, 2ꢃ HePhþH-60þH-
ꢀ
ꢀ
ꢀ
2000, 5, 1291; (f) Ravelo, A.; Estevez-Braun, A.; Chavez-Orellana, H.; Perez-
Sacau, E.; Mesa-Silverio, D. Curr. Top. Med. Chem. 2004, 4, 241; (g) Solorio-Al-
~
ꢀ
ꢀ
varado, C. R.; Pena-Cabrera, E.; García-Solto, J.; Lopez-Godínez, J.; Gonzalez, F. J.;
ꢀ
Alvarez-Hernandez, A. Arkivoc 2009, 239.
2. Karci, F.; Ertan, N. Color. Technol. 2005, 121, 153.
3. Barange, D. K.; Kavala, V.; Raju, B. R.; Kuo, C.-W.; Tseng, C.; Tu, Y.-C.; Yao, C.-F.
70); 7.98e8.19 (m, 2H, H-50þH-80); 13C NMR (
d, ppm, CD3COCD3):
Tetrahedron Lett. 2009, 50, 5116 and references cited therein.
45.4, 57.1, 64.0, 75.0, 76.0, 76.3, 76.5, 86.9, 92.7, 103.8, 123.8, 124.0,
126.7, 127.2, 127.8, 128.3, 128.9, 129.4, 129.7, 130.2, 141.4, 150.8,
153.8; MS (CI, m/z, %): 469 (5, Mþ); 133 (100); 91 (25, [PhCH2]þ).
Anal. Calcd for C25H27NO8: C, 63.96; H, 5.80; N, 2.98. Found: C,
63.71; H, 5.59; N 3.29.
ꢀ
4. (a) Sacau, E. P.; Estevez-Braun, A.; Ravelo, A. G.; Ferro, E. A.; Tokuda, H.; Mu-
kainakac, T.; Nishino, H. Bioorg. Med. Chem. 2003, 11, 483; (b) Baramee, A.;
Coppin, A.; Mortuaire, M.; Pelinski, L.; Tomavoc, S.; Brocard, J. Bioorg. Med.
Chem. 2006, 14, 1294; (c) Eyong, K.; Kumar, P. S.; Kuete, V.; Folefoc, G. N.;
Nkengfack, E. A.; Baskaran, S. Bioorg. Med. Chem. Lett. 2008, 18, 5387 and ref-
erences cited therein.
5. Harrity, J. P. A.; Kerr, W. J.; Middlemiss, D.; Scott, J. S. J. Organomet. Chem. 1997,
532, 219 and references cited therein.
3.1.13. (1R,2S,3S,4R,5S,6S)-6-Amino-3-(benzyloxy)-5-(10,40-dime-
thoxynaphthalen-20-yl)cyclohexane-1,2,4-triol (25). A degassed
suspension of compound 24 (61 mg, 0.13 mmol) and Ni-Raney
(0.100 g) in methanol (5 mL) was stirred under a hydrogen atmo-
sphere at rt during 3 h. The suspension was filtered over Celite and
the filtrate was concentrated to dryness under vacuum providing
the amino derivative 25 (53 mg, 95% yield) as a colorless oil, which
was reacted without further purification.
ꢀ
ꢀ
6. (a) Estevez, J. C.; Estevez, R. J.; Castedo, L. Tetrahedron Lett. 1993, 34, 6479; (b)
€
Luo, Y.-L.; Chou, T.-C.; Cheng, C. C. J. Heterocycl. Chem. 1996, 33, 113; (c) Knolker,
ꢀ
H.-J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303; (d) Cruces, J.; Estevez, J. C.;
ꢀ
Castedo, L.; Estevez, R. J. Tetrahedron Lett. 2001, 42, 4825; (e) Cruces, J.;
ꢀ
ꢀ
Martínez, E.; Treus, M.; Martínez, L. A.; Estevez, J. C.; Estevez, R. J.; Castedo, L.
ꢀ
ꢀ
Tetrahedron 2002, 58, 3015; (f) Barcia, J. C.; Cruces, J.; Estevez, J. C.; Estevez, R. J.;
Castedo, L. Tetrahedron Lett. 2002, 43, 5141; (g) Fernandez, M.; Barcia, C.;
ꢀ
ꢀ
ꢀ
Estevez, J. C.; Estevez, R. J.; Castedo, L. Synlett 2004, 267; (h) Asche, C.; Frank,
W.; Albert, A.; Kucklaender, U. Bioorg. Med. Chem. 2005, 13, 819; (i) Bernando,
P. H.; Chai, C. L. L.; Le Guen, M.; Smith, G. D.; Waring, P. Bioorg. Med. Chem. Lett.
2007, 17, 82; (j) Khan, Q. A.; Lu, J.; Hecht, S. M. J. Nat. Prod. 2009, 72, 438.
7. Ceng, C. C. In Progress in Medicinal Chemistry, Structural Aspects of Antineoplastic
AgentsdA New Approach; Ellis, G. P., West, G. B., Eds.; Elsevier: Amsterdam,
1988; Vol. 25.
3.1.14. (1R,2S,3S,4R,5S,6S)-6-Amino-3-O-benzyloxy-1,2,4-trihydroxy-
5-(10,40-naphthoquinon-20-yl)cyclohexane (26). A solution of cerium
ammonium nitrate (200 mg, 0.36 mmol) in acetonitrile (1 mL) and
water (1 mL), was added to a solution of compound 25 (53 mg,
0.12 mmol) in acetonitrile (9 mL) and water (1 mL) at 0 ꢁC and the
reaction mixture was stirred for 1 h. The solution was concentrated
to dryness under vacuum and the solid residue was dissolved in
8. Rehn, C.; Pindur, U. Monatsh. Chem. 1996, 127, 645.
9. Pettit, G. R.; Gaddamidi, V.; Cragg, G. M. J. Nat. Prod. 1984, 47, 1018.
10. (a) Gabrielsen, B.; Monath, T. P.; Huggins, J. W.; Kirsi, J. J.; Hollingshead, M.;
Shannon, W. M.; Pettit, G. R. In Natural Products as Antiviral Agents; Chu, C. K.,
Cutler, H. G., Eds.; Plenum: New York, NY, 1992, pp 121e135; (b) Patel, R. M.;
Prajapati, R. N. Biotechnol. Mol. Biol. Rev. 2011, 6, 59.